Grindeks AS | Cash Flow

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
16,291.50
1,901.20
1,442.60
6,170.20
8,807.30
8,841.80
Depreciation, Depletion & Amortization
4,687.10
5,177.70
5,897.60
5,617.50
5,938.40
5,746.60
Other Funds
-
-
274.80
22.70
332.60
976.50
Funds from Operations
16,412.40
801.30
8,014.70
11,989.70
10,997.20
2,118.60
Changes in Working Capital
610.90
4,704.50
5,233.40
5,778.90
6,034.00
6,137.40
Net Operating Cash Flow
17,023.30
5,505.80
2,781.40
6,210.80
17,031.20
4,018.70
Capital Expenditures
5,730.30
3,654.90
3,613.00
5,376.30
7,057.30
Sale of Fixed Assets & Businesses
19.70
0.60
-
-
-
Purchase/Sale of Investments
6,540.00
116.70
141.80
3,371.50
3,034.10
Net Investing Cash Flow
13,020.60
5,271.10
3,797.40
8,747.80
10,091.40
Cash Dividends Paid - Total
-
-
9,000.00
-
1,437.80
Issuance/Reduction of Debt, Net
2,600.10
1,640.60
8,274.70
3,505.10
2,749.40
Net Financing Cash Flow
2,600.10
1,640.60
450.60
3,527.80
3,854.60
Net Change in Cash
1,402.60
1,405.80
1,466.60
990.80
3,085.20
Free Cash Flow
11,293.00
1,850.80
831.60
834.40
11,195.80
Other Uses
770.00
1,500.00
42.60
-
-

About Grindeks AS

View Profile
Address
Krustpils iela 53
Riga RA LV
Latvia
Employees -
Website http://www.grindeks.lv
Updated 07/08/2019
Grindeks PJSC is a pharmaceutical company, which engages in the research, development, manufacture, and sale of original products, generics, and active pharmaceutical products. Its services include registration, contract manufacturing, and analytical. The company was founded in 1946 and is headquartered in Riga, Latvia.